How does the ASH 2021 data contribute to the roadmap for a cure for newly-diagnosed multiple myeloma?

Learning objective:

After participating in this webinar, viewers should be able to:

• Evaluate how the data from ASH 2021 informs the clinical management of patients with newly-diagnosed multiple myeloma

Faculty:

• Michel Delforge (Belgium)
• Maria-Victoria Mateos (Spain)
• Mohamad Mohty (France)
• Rakesh Popat (UK)
• Niels van de Donk (Netherlands)
• Roberto Mina (Italy)